Response to antidepressants in major depressive disorder with melancholic features: The CRESCEND study

Su Jin Yang, Robert Stewart, Hee Ju Kang, Seon Young Kim, Kyung Yeol Bae, Jae Min Kim, Sung Won Jung, Min-Soo Lee, Hyeon Woo Yim, Tae Youn Jun

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: This study aimed to determine whether major depressive disorders with melancholic and without melancholic features differ with respect to their responses to treatment with antidepressants. Methods: From a nationwide sample of 18 hospitals in South Korea, 559 presenting patients with major depressive disorder were recruited. The DSM-IV based Structured Clinical Interview was administered for confirmatory diagnoses and depression subtypes with/without melancholic features. After baseline evaluation, they received naturalistic clinician-determined antidepressant interventions. Assessment scales for evaluating depression (HAMD), anxiety (HAMA), global severity (CGI-s), and functioning (SOFAS) were administered at baseline and re-evaluated at 1, 2, 4, 8, and 12 weeks later. Results: At baseline, the 243 (43.5%) participants with melancholic features were more likely to have a previous history of depression, and had higher HAMA and lower SOFAS scores. After adjustment for baseline status, participants with melancholic features were more likely to achieve and to experience shorter times to CGI-s remission and associated with an enhanced global symptomatic remission with any antidepressant treatment. They were more likely to achieve and to experience shorter times to CGI-s remission and this difference was strongest in those receiving selective serotonin reuptake inhibitor (SSRI) antidepressants treatment. Limitations: The study was observational, and the treatment modality was naturalistic. Conclusions: These findings suggest a faster and more evident global response to pharmacotherapy in melancholia compared to other depressive syndromes, particularly where SSRI agents are used.

Original languageEnglish
Pages (from-to)42-50
Number of pages9
JournalJournal of Affective Disorders
Volume144
Issue number1-2
DOIs
Publication statusPublished - 2013 Jan 10

Fingerprint

Major Depressive Disorder
Antidepressive Agents
Serotonin Uptake Inhibitors
Depression
Depressive Disorder
Anxiety
Organ Dysfunction Scores
Republic of Korea
Therapeutics
Diagnostic and Statistical Manual of Mental Disorders
Observational Studies
Interviews
Drug Therapy

Keywords

  • Antidepressants
  • Depression
  • Korea
  • Melancholia
  • Response

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Yang, S. J., Stewart, R., Kang, H. J., Kim, S. Y., Bae, K. Y., Kim, J. M., ... Jun, T. Y. (2013). Response to antidepressants in major depressive disorder with melancholic features: The CRESCEND study. Journal of Affective Disorders, 144(1-2), 42-50. https://doi.org/10.1016/j.jad.2012.06.004

Response to antidepressants in major depressive disorder with melancholic features : The CRESCEND study. / Yang, Su Jin; Stewart, Robert; Kang, Hee Ju; Kim, Seon Young; Bae, Kyung Yeol; Kim, Jae Min; Jung, Sung Won; Lee, Min-Soo; Yim, Hyeon Woo; Jun, Tae Youn.

In: Journal of Affective Disorders, Vol. 144, No. 1-2, 10.01.2013, p. 42-50.

Research output: Contribution to journalArticle

Yang, SJ, Stewart, R, Kang, HJ, Kim, SY, Bae, KY, Kim, JM, Jung, SW, Lee, M-S, Yim, HW & Jun, TY 2013, 'Response to antidepressants in major depressive disorder with melancholic features: The CRESCEND study', Journal of Affective Disorders, vol. 144, no. 1-2, pp. 42-50. https://doi.org/10.1016/j.jad.2012.06.004
Yang, Su Jin ; Stewart, Robert ; Kang, Hee Ju ; Kim, Seon Young ; Bae, Kyung Yeol ; Kim, Jae Min ; Jung, Sung Won ; Lee, Min-Soo ; Yim, Hyeon Woo ; Jun, Tae Youn. / Response to antidepressants in major depressive disorder with melancholic features : The CRESCEND study. In: Journal of Affective Disorders. 2013 ; Vol. 144, No. 1-2. pp. 42-50.
@article{bcaa8fb49c304c10b57606b2110245f0,
title = "Response to antidepressants in major depressive disorder with melancholic features: The CRESCEND study",
abstract = "Background: This study aimed to determine whether major depressive disorders with melancholic and without melancholic features differ with respect to their responses to treatment with antidepressants. Methods: From a nationwide sample of 18 hospitals in South Korea, 559 presenting patients with major depressive disorder were recruited. The DSM-IV based Structured Clinical Interview was administered for confirmatory diagnoses and depression subtypes with/without melancholic features. After baseline evaluation, they received naturalistic clinician-determined antidepressant interventions. Assessment scales for evaluating depression (HAMD), anxiety (HAMA), global severity (CGI-s), and functioning (SOFAS) were administered at baseline and re-evaluated at 1, 2, 4, 8, and 12 weeks later. Results: At baseline, the 243 (43.5{\%}) participants with melancholic features were more likely to have a previous history of depression, and had higher HAMA and lower SOFAS scores. After adjustment for baseline status, participants with melancholic features were more likely to achieve and to experience shorter times to CGI-s remission and associated with an enhanced global symptomatic remission with any antidepressant treatment. They were more likely to achieve and to experience shorter times to CGI-s remission and this difference was strongest in those receiving selective serotonin reuptake inhibitor (SSRI) antidepressants treatment. Limitations: The study was observational, and the treatment modality was naturalistic. Conclusions: These findings suggest a faster and more evident global response to pharmacotherapy in melancholia compared to other depressive syndromes, particularly where SSRI agents are used.",
keywords = "Antidepressants, Depression, Korea, Melancholia, Response",
author = "Yang, {Su Jin} and Robert Stewart and Kang, {Hee Ju} and Kim, {Seon Young} and Bae, {Kyung Yeol} and Kim, {Jae Min} and Jung, {Sung Won} and Min-Soo Lee and Yim, {Hyeon Woo} and Jun, {Tae Youn}",
year = "2013",
month = "1",
day = "10",
doi = "10.1016/j.jad.2012.06.004",
language = "English",
volume = "144",
pages = "42--50",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Response to antidepressants in major depressive disorder with melancholic features

T2 - The CRESCEND study

AU - Yang, Su Jin

AU - Stewart, Robert

AU - Kang, Hee Ju

AU - Kim, Seon Young

AU - Bae, Kyung Yeol

AU - Kim, Jae Min

AU - Jung, Sung Won

AU - Lee, Min-Soo

AU - Yim, Hyeon Woo

AU - Jun, Tae Youn

PY - 2013/1/10

Y1 - 2013/1/10

N2 - Background: This study aimed to determine whether major depressive disorders with melancholic and without melancholic features differ with respect to their responses to treatment with antidepressants. Methods: From a nationwide sample of 18 hospitals in South Korea, 559 presenting patients with major depressive disorder were recruited. The DSM-IV based Structured Clinical Interview was administered for confirmatory diagnoses and depression subtypes with/without melancholic features. After baseline evaluation, they received naturalistic clinician-determined antidepressant interventions. Assessment scales for evaluating depression (HAMD), anxiety (HAMA), global severity (CGI-s), and functioning (SOFAS) were administered at baseline and re-evaluated at 1, 2, 4, 8, and 12 weeks later. Results: At baseline, the 243 (43.5%) participants with melancholic features were more likely to have a previous history of depression, and had higher HAMA and lower SOFAS scores. After adjustment for baseline status, participants with melancholic features were more likely to achieve and to experience shorter times to CGI-s remission and associated with an enhanced global symptomatic remission with any antidepressant treatment. They were more likely to achieve and to experience shorter times to CGI-s remission and this difference was strongest in those receiving selective serotonin reuptake inhibitor (SSRI) antidepressants treatment. Limitations: The study was observational, and the treatment modality was naturalistic. Conclusions: These findings suggest a faster and more evident global response to pharmacotherapy in melancholia compared to other depressive syndromes, particularly where SSRI agents are used.

AB - Background: This study aimed to determine whether major depressive disorders with melancholic and without melancholic features differ with respect to their responses to treatment with antidepressants. Methods: From a nationwide sample of 18 hospitals in South Korea, 559 presenting patients with major depressive disorder were recruited. The DSM-IV based Structured Clinical Interview was administered for confirmatory diagnoses and depression subtypes with/without melancholic features. After baseline evaluation, they received naturalistic clinician-determined antidepressant interventions. Assessment scales for evaluating depression (HAMD), anxiety (HAMA), global severity (CGI-s), and functioning (SOFAS) were administered at baseline and re-evaluated at 1, 2, 4, 8, and 12 weeks later. Results: At baseline, the 243 (43.5%) participants with melancholic features were more likely to have a previous history of depression, and had higher HAMA and lower SOFAS scores. After adjustment for baseline status, participants with melancholic features were more likely to achieve and to experience shorter times to CGI-s remission and associated with an enhanced global symptomatic remission with any antidepressant treatment. They were more likely to achieve and to experience shorter times to CGI-s remission and this difference was strongest in those receiving selective serotonin reuptake inhibitor (SSRI) antidepressants treatment. Limitations: The study was observational, and the treatment modality was naturalistic. Conclusions: These findings suggest a faster and more evident global response to pharmacotherapy in melancholia compared to other depressive syndromes, particularly where SSRI agents are used.

KW - Antidepressants

KW - Depression

KW - Korea

KW - Melancholia

KW - Response

UR - http://www.scopus.com/inward/record.url?scp=84870297441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870297441&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2012.06.004

DO - 10.1016/j.jad.2012.06.004

M3 - Article

C2 - 22840632

AN - SCOPUS:84870297441

VL - 144

SP - 42

EP - 50

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

IS - 1-2

ER -